Chardan Capital Markets Assumes Reviva Pharmaceuticals (RVPH) at Buy

January 5, 2026 4:23 AM EST Send to a Friend
(Updated - January 5, 2026 4:35 AM EST)

Chardan Capital Markets analyst Keay Nakae assumes coverage on Reviva Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login